Eli Lilly and Company
NEUREGULIN-4 COMPOUNDS AND METHODS OF USE
Last updated:
Abstract:
The present invention relates to neuregulin (NRG) 4 compounds and methods of treatment with NRG4 compounds.
Status:
Application
Type:
Utility
Filling date:
31 Mar 2020
Issue date:
12 Nov 2020